Bristol Myers Squibb (BMY) Partners with Pathos AI to Advance Neurological Disorder Research

gurufocus.com · 2026-10-23

On October 23, 2026, Bristol Myers Squibb Co (NYSE: BMY) announced a strategic three-year collaboration with Pathos AI to utilize its AI platform, Foundry, for

Read the full story at gurufocus.com →